Although the impact on weight loss is less pronounced than that of GLP-1RA, inhibition of DPP-4 activity is another potent strategy for preserving both GLP-1 and GIP endogenous production, and therefore enhancing incretin-induced insulin secretion in T2D [141]. Here, DPP4 is linked to type 2 diabetes mellitus.